Jeil Pharmaceutical Co.,Ltd (KRX:271980)

Market Cap	234.31B
Revenue (ttm)	621.98B
Net Income (ttm)	19.64B
Shares Out	14.57M
EPS (ttm)	1,347.81
PE Ratio	11.93
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	37,925
Average Volume	40,503
Open	15,850
Previous Close	15,710
Day's Range	15,510 - 16,160
52-Week Range	10,390 - 17,800
Beta	0.54
RSI	59.15
Earnings Date	Mar 13, 2026

About KRX:271980

Jeil Pharmaceutical Co.,Ltd develops and supplies pharmaceutical products primarily in South Korea. It provides products in the areas of antibiotic, gastrointestinal, cardiovascular, neuropsychiatry, oncology, endocrinology, urology, antiviral, and antihistamine. The company also exports its products to approximately 40 countries in ASEAN, Central and South America, Africa, and internationally. Jeil Pharmaceutical Co.,Ltd was founded in 1959 and is headquartered in Seoul, South Korea.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1959
• Employees: 947
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 271980